Arda is a driven and results-oriented strategy, licensing, and business development professional with a diverse background encompassing biotechnology, radiopharmaceuticals, radionuclides, radiotherapeutics, theranostics, nuclear medicine, digital health-focused medical devices, and genetic businessesWith a strong foundation in clinical research and regulatory affairs, Arda has played pivotal roles within various organizations, leading the charge in market entry strategies, product development, and clinical trial oversight. His expertise extends to supply chain optimization, logistics, and distribution within the clinical trial landscape.Arda's international experience is extensive, having traveled to over 50 countries in the life sciences industry over the past decades. He has successfully navigated complex mergers and acquisitions in both the USA and Europe, demonstrating a keen understanding of global business dynamics.In addition to his accomplishments in radiopharmaceuticals and medical devices, Arda has made significant contributions to the genetic business sector. He has been instrumental in driving strategic deals and managing genetic labs within this domain, leveraging his comprehensive understanding of genetic technologies and market trends.Arda's leadership extends to the establishment of cGMP-compliant radiopharmaceutical manufacturing facilities in various countries, including Bulgaria, Jordan, and Poland. Furthermore, his expertise in turn-key project services has facilitated market entry strategies for emerging markets such as Azerbaijan and Pakistan.With a track record of success and a commitment to excellence, Arda is well-equipped to tackle the challenges of today's rapidly evolving business landscape.